Ke-qi Wang
415 Fengyang Road
Shanghai, 200003, China
Shanghai, 200003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reply to "Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension: how much of the benefit is bile-acid specific?"
Journal: Journal of hepatology
Published: August 17, 2026
SOX9 promotes hepatocyte proliferation via upregulating TGF-α expression during liver regeneration.
Journal: Hepatology international
Published: June 04, 2025
Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 07, 2025
Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension.
Journal: Gastroenterology
Published: September 28, 2023
TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
Journal: Journal of hepatology
Published: July 11, 2023
Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.
Journal: FEBS letters
Published: March 21, 2017
Matrine derivate MASM suppresses LPS-induced phenotypic and functional maturation of murine bone marrow-derived dendritic cells.
Journal: International immunopharmacology
Published: January 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026